FindTrial
Sign In

A randomized controlled study of the clinical efficacy of robot-assisted radical anterograde modular pancreaticosplenectomy (RAMPS)

A randomized controlled study of the clinical efficacy of robot-assisted radical anterograde modular pancreaticosplenectomy (RAMPS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020833
Enrollment
Unknown
Registered
2019-01-20
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

Group 1:Robotic radical anterograde modular pancreaticosplenectomy (RAMPS)
Group2:conventional robotic surgery

Sponsors

PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Preoperative pathologic al examination or clinical judgment of resection or possible resection; 2. It meets the indications of resection of pancreatic somatococcygeal carcinoma by robot; 3. Postoperative pathological diagnosis of pancreatic ductal adenocarcinoma; 4. No other malignant tumors were complicated or secondary; 5. Complete clinical data.

Exclusion criteria

Exclusion criteria: 1. Preoperative imaging examination or intraoperative exploration revealed distant metastasis and abandonment of surgery; 2. Preoperative chemotherapy or radiotherapy; 3. Patients with major complications who cannot tolerate surgery.

Design outcomes

Primary

MeasureTime frame
Whether the tumor is eradicated;Postoperative complications;Perioperative indicators;—

Secondary

MeasureTime frame
Prognosis condition;—

Countries

China

Contacts

Public ContactZhang Gong

PLA General Hospital

zhanggong1993@hotmail.com+86 15202214739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 27, 2026